NRC proposes updated guidance for patients receiving radioactive material

The U.S. Nuclear Regulatory Commission (NRC) is asking for comments on its proposed revision to a guidance document provided to patients receiving radioactive material.

The proposed revision (Revision 1) applies to the guide: “Release of Patients Administered Radioactive Material,” according to a release from the Society of Nuclear Medicine and Molecular Imaging (SNMMI). It would provide licensees with more information to give to patients.

Included in the proposed revision is:

  • Specific safety information to offer patient before and after they have received radioactive material for an exam
  • A new section on “Death of a Patient Following Radiopharmaceutical or Implants Administration”
  • An updated table for “Dosages of Radiopharmaceuticals That Require Instructions and Records When Administered to Patients Who Are Breastfeeding an Infant or Child,”
  • Detailed information about record-keeping

“NRC regulatory guidance documents, such as this one, describe enforcement methods used by regulators and provide licensees with implementation guidance beyond regulations,” the SNMMI release read.

Comments must be submitted by Aug. 26. Read the full proposal here.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.